Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations

BACKGROUND: The amplification of epidermal growth factor receptor (EGFR) in triple negative breast carcinomas (TNBC) suggests its potential therapeutic application, as for HER-2, using standardised methods of measurement. In this regard, we aimed to compare several methods for evaluating EGFR amplif...

Descripción completa

Detalles Bibliográficos
Autores principales: Secq, V, Villeret, J, Fina, F, Carmassi, M, Carcopino, X, Garcia, S, Metellus, I, Boubli, L, Iovanna, J, Charpin, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929875/
https://www.ncbi.nlm.nih.gov/pubmed/24423920
http://dx.doi.org/10.1038/bjc.2013.794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929875/
https://www.ncbi.nlm.nih.gov/pubmed/24423920
http://dx.doi.org/10.1038/bjc.2013.794

Ejemplares similares